Christopher S. Hassan
Geen lopende functies
Profiel
Christopher S.
Hassan is a Director and Senior Executive Vice President of Hythiam, Inc., which he joined in July 2006.
He had been Vice President-Sales of Reckitt Benckiser Pharmaceuticals since October 2003.
Mr. Hassan was Director-North America Sales of Drugabuse Sciences, Inc. from 2000 to October 2002.
He was Area Business Manager of Parke-Davis/Pfizer from 1996 to 2000 and District Sales Manager for Bayer Pharmaceuticals from 1989 to 1996.
Mr. Hassan received a BBA in Accounting from the University of Texas, Austin.
Eerdere bekende functies van Christopher S. Hassan
| Bedrijven | Functie | Einde |
|---|---|---|
| ONTRAK, INC. | Corporate Officer/Principal | 16-04-2010 |
| ONTRAK, INC. | Directeur/Bestuurslid | 17-07-2009 |
| Drugabuse Sciences, Inc. | Verkoop & Marketing | 01-10-2002 |
| Parke, Davis & Co. LLC | Corporate Officer/Principal | 01-01-2000 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2000 |
Opleiding van Christopher S. Hassan
| The University of Texas at Austin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ONTRAK, INC. | Health Services |
| Bedrijven in privébezit | 4 |
|---|---|
| Bayer Pharmaceuticals Corp. | |
| Parke, Davis & Co. LLC | |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Health Technology |
| Drugabuse Sciences, Inc. |
